|
Amitava Dasgupta received his PhD in chemistry from Stanford University and completed his fellowship in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry and a member of ADLM since 1987. He is also a fellow of the academy. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Hospital. In 2009, he received the Irvine Sunshine Award from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for his outstanding contribution in toxicology research.
|